Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT06067295
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Key Dates

Start date
Feb 21, 2023
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Primary Outcome Measure

Collection of biological specimens and clinical data for future research related to prostate cancer. [ Time Frame: Up to 5 years ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Los Angeles General Medical CenterLos AngelesCalifornia90033
Cheryl Kefauver, RN
[email protected]
323-865-0459
Amir Goldkorn, MD (PRINCIPAL_INVESTIGATOR)
USC / Norris Comprehensive Cancer CenterLos AngelesCalifornia90033
Cheryl Kefauver, RN
[email protected]
323-865-0459
Amir Goldkorn, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Los Angeles General Medical Center· Los Angeles, CAUSC / Norris Comprehensive Cancer Center· Los Angeles, CA

Related Studies